Article Details

Libtayo® (cemiplimab) Neoadjuvant Treatment Demonstrates - GlobeNewswire

Retrieved on: 2023-10-21 18:51:50

Tags for this article:

Click the tags to see associated articles and topics

Libtayo® (cemiplimab) Neoadjuvant Treatment Demonstrates - GlobeNewswire. View article details on hiswai:

Excerpt

have immune system problems such as Crohn's disease, ulcerative colitis, or lupus · have received an organ transplant ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up